Literature DB >> 10905491

Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase.

A T Cheung1, J Wang, D Ree, J K Kolls, M Bryer-Ash.   

Abstract

The molecular mechanism whereby tumor necrosis factor-alpha (TNF-alpha) induces insulin resistance in obesity is not well understood. Previously, we have shown that inhibition of TNF-alpha improved hepatic insulin sensitivity in obese Zucker rats without altering the tyrosine phosphorylation of liver insulin receptors (IRs), which indicates that the TNF-alpha and insulin-signaling cascades interact distally to the IR. To assess the effects of TNF-alpha on signaling molecules downstream from the IR, we analyzed the tyrosine phosphorylation patterns of liver homogenate proteins from TNF-alpha-neutralized fa/fa rats and showed that focal adhesion kinase (FAK) was consistently hyperphosphorylated (4.5-fold). Moreover, intravenous insulin increased hepatic FAK phosphorylation in a time-dependent manner in Sprague-Dawley rats, which suggests that TNF-alpha may induce hepatic insulin resistance by preventing FAK phosphorylation in response to insulin treatment. To explore the cellular mechanism whereby TNF-alpha regulates phosphorylation of FAK in the liver, we measured c-Src kinase activity and the abundance of 3 major protein tyrosine phosphatases (PTPs) (PTP-1B, leukocyte antigen-related tyrosine phosphatase [LAR], and src homology 2 domain-containing protein-tyrosine phosphatase [SHPTP-2]) in liver homogenates from obese Zucker rats after TNF-alpha blockade. Hepatic c-Src kinase activity was unaltered, but LAR protein was reduced by 75%. In addition, TNF-alpha blockade reduced hepatic PTP activity toward tyrosine phosphorylated FAK by 70%, and this was accounted for by immunodepletion of LAR. Incubation of HepG2 cells with TNF-alpha increased LAR protein levels in a dose-dependent manner. Additionally, pretreatment with TNF-alpha abolished insulin-stimulated tyrosine phosphorylation of FAK in HepG2 cells but had no effect on IR tyrosine phosphorylation or expression. These data suggest that TNF-alpha promotes LAR expression and thus prevents insulin-mediated tyrosine phosphorylation of FAK. This probably represents the interface between TNF-alpha and insulin signaling in the liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905491     DOI: 10.2337/diabetes.49.5.810

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

1.  Regulation of adipose tissue inflammation by adenosine 2A receptor in obese mice.

Authors:  Ya Pei; Honggui Li; Yuli Cai; Jing Zhou; Xianjun Luo; Linqiang Ma; Kelly McDaniel; Tianshu Zeng; Yanming Chen; Xiaoxian Qian; Yuqing Huo; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Lulu Chen; Chaodong Wu
Journal:  J Endocrinol       Date:  2018-12-01       Impact factor: 4.286

Review 2.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

3.  Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis.

Authors:  Noha F Hassan; Somaia A Nada; Azza Hassan; Mona R El-Ansary; Muhammad Y Al-Shorbagy; Rania M Abdelsalam
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 4.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

5.  Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation.

Authors:  Massimo Collino; Manuela Aragno; Sara Castiglia; Gianluca Miglio; Chiara Tomasinelli; Giuseppe Boccuzzi; Christoph Thiemermann; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2010-03-08       Impact factor: 8.739

6.  Myeloid cell-specific disruption of Period1 and Period2 exacerbates diet-induced inflammation and insulin resistance.

Authors:  Hang Xu; Honggui Li; Shih-Lung Woo; Sam-Moon Kim; Vikram R Shende; Nichole Neuendorff; Xin Guo; Ting Guo; Ting Qi; Ya Pei; Yan Zhao; Xiang Hu; Jiajia Zhao; Lili Chen; Lulu Chen; Jun-Yuan Ji; Robert C Alaniz; David J Earnest; Chaodong Wu
Journal:  J Biol Chem       Date:  2014-04-25       Impact factor: 5.157

7.  Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression.

Authors:  S Fernández-Veledo; I Nieto-Vazquez; C M Rondinone; M Lorenzo
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

8.  Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.

Authors:  Janice M Zabolotny; Young-Bum Kim; Laura A Welsh; Erin E Kershaw; Benjamin G Neel; Barbara B Kahn
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

9.  Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response.

Authors:  Yuqing Huo; Xin Guo; Honggui Li; Huan Wang; Weiyu Zhang; Ying Wang; Huaijun Zhou; Zhanguo Gao; Sucheta Telang; Jason Chesney; Y Eugene Chen; Jianping Ye; Robert S Chapkin; Chaodong Wu
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

10.  In vivo inhibition of focal adhesion kinase causes insulin resistance.

Authors:  Bharti Bisht; K Srinivasan; Chinmoy S Dey
Journal:  J Physiol       Date:  2008-06-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.